What is the rate of gestational diabetes in twin pregnancies compared to singleton pregnancies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gestational Diabetes in Twin Pregnancies: Incidence and Comparison to Singleton Pregnancies

Twin pregnancies have approximately twice the risk of developing gestational diabetes mellitus compared to singleton pregnancies, with rates of 7.7-9.6% in twins versus 4.1-7.6% in singletons. 1, 2, 3

Epidemiology and Risk Factors

  • Twin pregnancies show a significantly higher incidence of gestational diabetes mellitus (GDM) compared to singleton pregnancies:

    • 7.7% vs 4.1% (p<0.05) 1
    • 9.6% vs 7.6% 2
    • 3.98% vs 2.32% (p=0.01) 3
  • After adjusting for confounding variables (age, race/ethnicity, BMI, blood pressure, smoking, parity), twin pregnancy is associated with approximately twice the risk for developing GDM (OR 2.2,95% CI 1.4-3.6) 3

  • Highest risk groups for GDM in twin pregnancies:

    • Women between ages 25-30 years
    • African-American women 3

Pathophysiology

  • The increased risk of GDM in twin pregnancies is likely due to greater insulin resistance associated with carrying multiple fetuses 4

  • Twin pregnancies demonstrate significantly higher 3-hour glucose tolerance test values compared to singleton pregnancies, indicating more pronounced glucose metabolism disturbances 1

  • However, insulin requirements for management are not significantly different between twin and singleton GDM pregnancies, suggesting a milder disturbance of carbohydrate tolerance that responds well to standard management approaches 1

Clinical Implications and Outcomes

Maternal Outcomes

  • GDM in twin pregnancies is associated with:

    • Increased risk of cesarean delivery (adjusted RR 1.11 [1.02-1.21]) 5
    • Higher rates of preterm birth at <37 weeks (adjusted RR 1.21 [1.08-1.37]) and <34 weeks (adjusted RR 1.45 [1.03-2.04]) 5
  • Unlike in singleton pregnancies, GDM in twins is NOT associated with:

    • Gestational hypertension
    • Preeclampsia 5

Fetal/Neonatal Outcomes

  • GDM in twin pregnancies is associated with:

    • 2.5-fold increased risk of birthweight >90th percentile (adjusted RR 2.53 [1.52-4.23]), which is twice the risk seen in singletons with GDM 5
    • Increased risk of neonatal jaundice (adjusted RR 1.56 [1.10-2.21]) 5
    • Higher rates of NICU admission (37% vs 52%, p=0.05) 3
    • Longer hospital stays (8±0.5 vs 16±4 days, p=0.01) 3
    • Increased respiratory distress syndrome (7% vs 27%, p=0.001) 3
  • Unlike in singleton pregnancies, GDM in twins is NOT associated with:

    • NICU admission (except as noted above)
    • Respiratory morbidity
    • Neonatal hypoglycemia 5

Fetal Growth Patterns

  • In contrast to singleton pregnancies where GDM is consistently associated with accelerated fetal growth starting around 30 weeks, twin pregnancies with diet-controlled GDM generally show similar growth patterns to non-GDM twin pregnancies 2

  • Accelerated fetal growth in twin pregnancies with GDM is primarily observed only in the subgroup requiring medical treatment (insulin or oral agents), which represents approximately 12% of twin pregnancies with GDM 2

Clinical Considerations

  • Current diagnostic criteria and management approaches for GDM in twin pregnancies are based on singleton pregnancy standards, which may not be optimal 4

  • Some evidence suggests that the increased insulin resistance in twin pregnancies may represent a physiological adaptation rather than pathology, particularly in diet-controlled cases 4

  • Strict glycemic control in diet-treated GDM twin pregnancies might potentially increase the risk of intrauterine growth restriction 4

  • Twin-specific screening and diagnostic criteria for GDM may be needed, with preliminary data suggesting higher optimal thresholds than those used for singleton pregnancies 4

Monitoring Recommendations

  • Multiple gestations require more intensive monitoring than singleton pregnancies, including:

    • First trimester dating scan
    • Nuchal translucency scan at 11-14 weeks
    • Anatomy scan at 18-22 weeks
    • One or more third-trimester growth scans 6
  • Twin pregnancies with GDM should be monitored with particular attention to fetal growth patterns, as the impact of GDM on growth differs from singleton pregnancies 2

Pitfalls and Caveats

  • Overdiagnosis of GDM in twin pregnancies may occur when using singleton criteria, potentially leading to unnecessary interventions 4

  • Overtreatment with strict glycemic targets might increase the risk of intrauterine growth restriction in twins 4

  • The higher baseline risk of complications in twin pregnancies (preterm birth, growth restriction) may mask or modify the typical GDM-associated complications seen in singleton pregnancies 5, 4

References

Research

Gestational diabetes and fetal growth in twin compared with singleton pregnancies.

American journal of obstetrics and gynecology, 2021

Research

Risk for developing gestational diabetes in women with twin pregnancies.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2009

Research

Gestational diabetes mellitus is associated with adverse outcomes in twin pregnancies.

American journal of obstetrics and gynecology, 2019

Guideline

Obstetrical Reporting Guidelines for Multiple Births

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.